CR

Chad Robins

Chief Executive Officer, Co-founder, Chairman of the Board

Adaptive Biotechnologies

Adaptive Biotechnologies Pipeline

DrugIndicationPhase
clonoSEQMultiple Myeloma (Bone Marrow)Approved
TCR Therapeutics PlatformCancer, Autoimmune, Infectious DiseaseDiscovery
Antibody Therapeutics PlatformInfectious Disease, CancerDiscovery
SARS-CoV-2 Neutralizing AntibodiesCOVID-19Discovery